Epidermal expression of I-TAC (Cxcl11) instructs adaptive Th2-type immunity

FASEB Journal

Volumn 28, Issue 4, 2014, Pages 1724-1734

  Roebrock, Kirsten ^a,b   Sunderkötter, Cord ^a,b   Münck, Niels Arne ^a   Wolf, Marc ^a   Nippe, Nadine ^a   Barczyk, Katarzyna ^a   Varga, Georg ^a   Vogl, Thomas ^a,b   Roth, Johannes ^a,b   Ehrchen, Jan ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Interdisciplinary Center for Clinical Research   (Germany)

Author keywords

Keratinocytes; Leishmaniasis

Indexed keywords

CXCL11 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; THYMIC STROMAL LYMPHOPOIETIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DETERIORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; IN VITRO STUDY; KERATINOCYTE; LASER MICRODISSECTION; LEISHMANIASIS; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; UPREGULATION;

KERATINOCYTES; LEISHMANIASIS;

ADAPTIVE IMMUNITY; ANIMALS; CHEMOKINE CXCL11; DENDRITIC CELLS; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HOST-PARASITE INTERACTIONS; IN SITU HYBRIDIZATION; INTERLEUKIN-12; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TH1 CELLS; TH2 CELLS;

EID: 84901009002     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-233593     Document Type: Article

References (55)

1. Sacks, D., and Noben-Trauth, N. (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2, 845-858
2. Von Stebut, E. (2007) Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy. Exp. Dermatol. 16, 340-346
3. Von Stebut, E., Ehrchen, J. M., Belkaid, Y., Kostka, S. L., Molle, K., Knop, J., Sunderkotter, C., and Udey, M. C. (2003) Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J. Exp. Med. 198, 191-199
4. Ehrchen, J. M., Roth, J., Roebrock, K., Varga, G., Domschke, W., Newberry, R., Sorg, C., Müller-Tidow, C., Sunderkötter, C., Kucharzik, T., and Spahn, T. W. (2008) The absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in mice. Infect. Immun. 76, 4241-4250
5. Sunderkötter, C., Kunz, M., Steinbrink, K., Meinardus-Hager, G., Goebeler, M., Bildau, H., and Sorg, C. (1993) Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo. J. Immunol. 151, 4891-4901
6. Tacchini-Cottier, F., Zweifel, C., Belkaid, Y., Mukankundiye, C., Vasei, M., Launois, P., Milon, G., and Louis, J. A. (2000) An immunomodulatory function for neutrophils during the induction of a CD4-Th2 response in BALB/c mice infected with Leishmania major. J. Immunol. 165, 2628-2636
7. Nabors, G. S., Nolan, T., Croop, W., Li, J., and Farrell, J. P. (1995) The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major. Parasite Immunol. 17, 569-579
8. Constant, S. L. Brogdon, J. L., Piggott, D. A., Herrick, C. A., Visintin, I., Ruddle, N. H., and Bottomly, K. (2002) Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J. Clin. Invest. 110, 1441-1448
9. Ehrchen, J. M., Roebrock, K., Foell, D., Nippe, N., von Stebut, E., Weiss, J. M., Münck, N.-A., Viemann, D., Varga, G., Müller-Tidow, C., Schuberth, H.-J., Roth, J., and Sunderkötter, C. (2010) Keratinocytes determine Th1 immunity during early experimental leishmaniasis. PLoS Pathog. 6, e1000871
10. Biedermann, T., Zimmermann, S., Himmelrich, H., Gumy, A., Egeter, O., Sakrauski, A. K., Seegmüller, I., Voigt, H., Launois, P. A., Levine, D., Wagner, H., Heeg, K., Louis, J. A., and Röcken, M. (2001) IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat. Immunol. 2, 1054-1060
11. Kapsenberg, M. L. (2003) Dendritic-cell control of pathogendriven T-cell polarization. Nat. Rev. Immunol. 3, 984-993
12. Kali ́ nski, P., Hilkens, C. M., Wierenga, E. A., and Kapsenberg, M. L. (1999) T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20, 561-567
13. Dong, C. (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8, 337-348
14. Amsen, D. J. M. Blander, G. R. Lee, Tanigaki, K., Honjo, T., and Flavell, R. A. (2004) Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117, 515-526
15. Ito, T., Wang, Y.-H., Duramad, O., Hori, T., Delespesse, G. J., Watanabe, N. F., Qin, X.-F., Yao, Z., Cao, W., and Liu, Y.-J. (2005) TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202, 1213-1223
16. Ehrchen, J., Helming, L., Varga, G., Pasche, B., Loser, K., Gunzer, M., Sunderkötter, C., Sorg, C., Roth, J., and Lengeling, A. (2007) Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. FASEB J. 21, 3208-3218
17. Westphal, G., Burgemeister, R., Friedemann, G., Wellmann, A., Wernert, N., Wollscheid, V., Becker, B., Vogt, T., Knüchel, R., Stolz, W., and Schütze, K. (2002) Noncontact laser catapulting: a basic procedure for functional genomics and proteomics. Methods Enzymol. 356, 80-99
18. Ehrchen, J., Heuer, H., Sigmund, R., Schäfer, M. K., and Bauer, K. (2001) Expression and regulation of osteopontin and connective tissue growth factor transcripts in rat anterior pituitary. J. Endocrinol. 169, 87-96
19. Cole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., Sahagan, B. G., and Neote, K. (1998) Interferoninducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187, 2009-2021
20. Iezzi, G., Fröhlich, A., Ernst, B., Ampenberger, F., Saeland, S., Glaichenhaus, N., and Kopf, M. (2006) Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection. J. Immunol. 177, 1250-1256
21. Nigg, A. P., Zahn, S., Rückerl, D., Hölscher, C., Yoshimoto, T., Ehrchen, J. M., Wölbing, F., Udey, M. C., and von Stebut, E. (2007) Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice. J. Immunol. 178, 7251-7258
22. Müller, K., van Zandbergen, G., Hansen, B., Laufs, H., Jahnke, N., Solbach, W., and Laskay, T. (2001) Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med. Microbiol. Immunol. 190, 73-76
23. Vester, B., Müller, K., Solbach, W., and Laskay, T. (1999) Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect. Immun. 67, 3155-3159
24. Matte, C., and Olivier, M. (2002) Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J. Infect. Dis. 185, 673-681
25. Antoniazi, S., Price, H. P., Kropf, P., Freudenberg, M. A., Galanos, C., Smith, D. F., and Müller, I. (2004) Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major. Infect. Immun. 72, 5168-5174
26. Katzman, S. D., and Fowell, D. J. (2008) Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infected tissue site. J. Clin. Invest. 118, 801-811
27. Loetscher, P., Pellegrino, A., Gong, J. H., Mattioli, I., Loetscher, M., Bardi, G., Baggiolini, M., and Clark-Lewis, I. (2001) The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J. Biol. Chem. 276, 2986-2991
28. Lindell, D. M., Lane, T. E., and Lukacs, N. W. (2008) CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(-) T cell efficacy. Eur. J. Immunol. 38, 2168-2179
29. Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., Wei, K., McMaster, B. E., Wright, K., Howard, M. C., and Schall, T. J. (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203, 2201-2213
30. Petkovic, V., Moghini, C., Paoletti, S., Uguccioni, M., and Gerber, B. (2004) I-TAC/CXCL11 is a natural antagonist for CCR5. J. Leukoc. Biol. 76, 701-708
31. Kanda, N., Shimizu, T., Tada, Y., and Watanabe, S. (2007) IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur. J. Immunol. 37, 338-350
32. Flier, J., Boorsma, D. M., van Beek, P. J., Nieboer, C., Stoof, T. J., Willemze, R., and Tensen, C. P. (2001) Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J. Pathol. 194, 398-405
33. Balashov, K. E., Rottman, J. B., Weiner, H. L., and Hancock, W. W. (1999) CCR5(-) and CXCR3(-) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U. S. A. 96, 6873-6878
34. Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., and Mackay, C. R. (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101, 746-754
35. De Jong, E. C., Vieira, P. L., Kalinski, P., and Kapsenberg, M. L. (1999) Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J. Leukoc. Biol. 66, 201-204
36. Corthay, A. (2006) A three-cell model for activation of naïve T helper cells. Scand. J. Immunol. 64, 93-96
37. Filippi, C., Hugues, S., Cazareth, J., Julia, V., Glaichenhaus, N., and Ugolini, S. (2003) CD4-T cell polarization in mice is modulated by strain-specific major histocompatibility complexindependent differences within dendritic cells. J. Exp. Med. 198, 201-209
38. Boonstra, A., Asselin-Paturel, C., Gilliet, M., Crain, C., Trinchieri, G., Liu, Y.-J., and O'Garra, A. (2003) Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 197, 101-109
39. Matzinger, P. (2007) Friendly and dangerous signals: is the tissue in control? Nat. Immunol. 8, 11-13
40. Whelan, M., Harnett, M. M., Houston, K. M., Patel, V., Harnett, W., and Rigley, K. P. (2000) A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J. Immunol. 164, 6453-6460
41. Caron, G., Delneste, Y., Roelandts, E., Duez, C., Bonnefoy, J. Y., Pestel, J., and Jeannin, P. (2001) Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol. 167, 3682-3686
42. Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., Smith, K., Gorman, D., Zurawski, S., Abrams, J., Menon, S., McClanahan, T., de Waal-Malefyt, R., Bazan, F., Kastelein, R. A., and Liu, Y.-J. (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3, 673-680
43. Newberry, R. D., McDonough, J. S., Stenson, W. F., and Lorenz, R. G. (2001) Spontaneous and continuous cyclooxygenase-2-dependent prostaglandin E2 production by stromal cells in the murine small intestine lamina propria: directing the tone of the intestinal immune response. J. Immunol. 166, 4465-4472
44. Braun, M. C., Lahey, E., and Kelsall, B. L. (2000) Selective suppression of IL-12 production by chemoattractants. J. Immunol. 164, 3009-3017
45. Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M., and Rollins, B. J. (2000) Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404, 407-411
46. Barbi, J., Brombacher, F., and Satoskar, A. R. (2008) T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation. J. Immunol. 181, 4613-4620
47. Holgate, S. T. (2007) The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol. 28, 248-251
48. Willart, M. A. M., and Lambrecht, B. N. (2009) The danger within: endogenous danger signals, atopy and asthma. Clin. Exp. Allergy 39, 12-19
49. Saenz, S. A., Taylor, B. C., and Artis, D. (2008) Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol. Rev. 226, 172-190
50. Allakhverdi, Z., Comeau, M. R., Jessup, H. K., Yoon, B.-R. P., Brewer, A., Chartier, S., Paquette, N., Ziegler, S. F., Sarfati, M., and Delespesse, G. (2007) Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J. Exp. Med. 204, 253-258
51. Liu, Y.-J., Soumelis, V., Watanabe, N., Ito, T., Wang, Y.-H., de Waal-Malefyt, R., Omori, M., Zhou, B., and Ziegler, S. F. (2007) TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu. Rev. Immunol. 25, 193-219
52. Taylor, B. C., Zaph, C. A., Troy, E., Du, Y., Guild, K. J., Comeau, M. R., and Artis, D. (2009) TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J. Exp. Med. 206, 655-667
53. Humphreys, N. E., Xu, D., Hepworth, M. R., Liew, F. Y., and Grencis, R. K. (2008) IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol. 180, 2443-2449
54. Owyang, A. M., Zaph, C., Wilson, E. H., Guild, K. J., McClanahan, T. H., Miller, R. P., Cua, D. J., Goldschmidt, M., Hunter, C. A., Kastelein, R. A., and Artis, D. (2006) Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J. Exp. Med. 203, 843-849
55. Cox, J. H., Dean, R. A., Roberts, C. R., and Overall, C. M. (2008) Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding. J. Biol. Chem. 283, 19389-19399